期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胸苷激酶1与血液肿瘤的相关性分析 被引量：1

下载PDF
导出
摘要 近年来,随着化学因素、物理因素、生物因素及污染等多种因素的诱发,使恶性血液病的发病率逐渐增高,而目前对恶性血液疾病的早期发现、早期诊断及对患者的病情监测及治疗效果的评估,尚缺少一个较为理想的血清学监测指标。胸苷激酶1(thymidine kinase-1,TKl)能将脱氧胸苷转化为胸苷酸,是合成DNA的关键酶,是一种与细胞周期性分裂有关的血生化指标,可在多种肿瘤患者的血清中检测到,
作者 孙祥君 初晓霞
机构地区 滨州医学院 山东省威海市中心医院 烟台毓璜顶医院
出处 《临床合理用药杂志》 2016年第4期170-173,共4页 Chinese Journal of Clinical Rational Drug Use
关键词 胸甘激酶1 血液肿瘤 急性白血病 慢性淋巴细胞白血病 淋巴病 骨髓增生异常综合征
分类号 R733 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1W Kern,T Haferlach,C Schoch,H Loffler,W Gassmann,A Heinecke,MC Sauerland,W Berdel,T Buchner,W Hiddemann.Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood . 2003
  • 2Ví,t Prochá,zka,Edgar Faber,Lud&ecaron,k Raida,Kate&rcaron,ina Langová,Karel Indrá,k,Tomá,&scaron,Papají,k.??High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma(J)Leukemia & Lymphoma . 2012 (7)
  • 3Wei Xu,Xin Cao,Kou-Rong Miao,Chun Qiao,Yu-Jie Wu,Qiong Liu,Lei Fan,Jian-Yong Li.??Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors(J)International Journal of Hematology . 2009 (2)
  • 4Quaternary Structure Change as a Mechanism for the Regulation of Thymidine Kinase 1-Like Enzymes(J)Structure . 2007 (12)
  • 5Namiko Kuroiwa,Masao Nakayama,Tamotsu Fukuda,Hideo Fukui,Hidemi Ohwada,Takaki Hiwasa,Shinji Fujimura.??Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibodies raised against recombinant human thymidine kinase(J)Journal of Immunological Methods . 2001 (1)
  • 6徐卫,沈秋丹,于慧,乔纯,吴雨洁,刘琼,朱丹霞,缪扣荣,李建勇.慢性淋巴细胞白血病患者脂蛋白酯酶和血清胸苷激酶水平及其与其他预后因素的相关性研究[J].中华血液学杂志,2009,30(1):8-12. 被引量：8
  • 7de la Serna Javier,Montesinos Pau,Vellenga Edo,Rayón Chelo,Parody Ricardo,León Angel,Esteve Jordi,Bergua Juan M,Milone Gustavo,Debén Guillermo,Rivas Concha,González Marcos,Tormo Mar,Díaz-Mediavilla Joaquín,González Jose D,Negri Silvi.Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood . 2008
  • 8Chen Zhiheng,Zhou Hui,Li Shenglan,He Ellen,Hu Jiyong,Zhou Ji,Skog Sven.Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours. Anticancer Research . 2009
  • 9K L O’Neill,F Zhang,H Li,D G Fuja,B K Murray.Thymidine kinase 1 – A prognostic and diagnostic indicator in ALL and AML patients. Leukemia . 2007
  • 10Sergej N. Konoplev,Herbert A. Fritsche,Susan O’Brien.High Serum Thymidine Kinase 1 Level Predicts Poorer Survival in Patients With Chronic Lymphocytic Leukemia. AMERICAN JOURNAL OF CLINICAL PATHOLOGY . 2010

二级参考文献45

  • 1涂植光.依托现代科学管理和技术 开展肿瘤标志物研究和应用[J].中华检验医学杂志,2006,29(4):289-292. 被引量：15
  • 2李丽,徐卫,李建勇.慢性淋巴细胞白血病预后因素研究进展[J].中华内科杂志,2006,45(9):781-783. 被引量：17
  • 3Oppezzo P, Vasconcelos Y, Settegrana C, et al. The LPL/ ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood, 2005,106 : 650-657.
  • 4Heintel D, Kienle D, Shehata M,et al. High expression nf lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia, 2005,19 : 1216-1223.
  • 5van' t Veer MB, Brooijmans AM, Langerak AW,et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica, 2006,91:56-63.
  • 6Bilban M, Heintel D, Scharl T,et al. Deregulated expression of lat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia, 2006, 20: 1080- 1088.
  • 7Binet Jl., Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 1981,48:198-206.
  • 8Chcn L, Zhang Y, Zheng W, et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Lenk Res, 2008,32 : 1491-1498.
  • 9Xu W, Li JY, Wu YJ, et al. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leuk Res, 2009, 33:237-243.
  • 10Xu W, Li JY, Wu YJ, et al. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. Lcuk Res, 2007,32 : 1071-1077.

共引文献62

同被引文献22

引证文献1

临床合理用药杂志
2016年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部